Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

Similar articles for PubMed (Select 19012428)

1.

Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease.

Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C, Mischak H, Metzger J.

J Proteome Res. 2009 Jan;8(1):268-81. doi: 10.1021/pr800401m.

PMID:
19012428
2.

Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients.

von Zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N, Vanholder RC, Dominiczak AF, Chen YC, Mischak H, Bode C, Peter K.

J Proteome Res. 2009 Jan;8(1):335-45. doi: 10.1021/pr800615t.

PMID:
19053529
3.

Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.

Fliser D, Wittke S, Mischak H.

Electrophoresis. 2005 Jul;26(14):2708-16. Review.

PMID:
15966014
4.

Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.

Metzger J, Luppa PB, Good DM, Mischak H.

Crit Rev Clin Lab Sci. 2009;46(3):129-52. doi: 10.1080/10408360902805261. Review.

PMID:
19404829
5.

High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.

Schiffer E, Mischak H, Novak J.

Proteomics. 2006 Oct;6(20):5615-27. Review.

PMID:
16991199
6.

Absolute quantification strategies in proteomics based on mass spectrometry.

Brönstrup M.

Expert Rev Proteomics. 2004 Dec;1(4):503-12. Review.

PMID:
15966845
7.

Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.

Mischak H, Delles C, Klein J, Schanstra JP.

Adv Chronic Kidney Dis. 2010 Nov;17(6):493-506. doi: 10.1053/j.ackd.2010.09.004. Review.

PMID:
21044772
8.

Isotope dilution strategies for absolute quantitative proteomics.

Brun V, Masselon C, Garin J, Dupuis A.

J Proteomics. 2009 Jul 21;72(5):740-9. doi: 10.1016/j.jprot.2009.03.007. Epub 2009 Mar 31. Review.

PMID:
19341828
9.

Quantitative mass spectrometry in proteomics: a critical review.

Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B.

Anal Bioanal Chem. 2007 Oct;389(4):1017-31. Epub 2007 Aug 1. Review.

PMID:
17668192
10.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Mol Cell Proteomics. 2010 Nov;9(11):2424-37. doi: 10.1074/mcp.M110.001917. Epub 2010 Jul 8.

11.

The emerging role of ICP-MS in proteomic analysis.

Bettmer J, Montes Bayón M, Encinar JR, Fernández Sánchez ML, Fernández de la Campa Mdel R, Sanz Medel A.

J Proteomics. 2009 Aug 20;72(6):989-1005. doi: 10.1016/j.jprot.2009.05.003. Epub 2009 May 24.

PMID:
19470414
12.

Proteomic analysis for the assessment of diabetic renal damage in humans.

Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, Knueppel S, Haller H, Fliser D.

Clin Sci (Lond). 2004 Nov;107(5):485-95.

13.

Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery.

Zürbig P, Schiffer E, Mischak H.

Methods Mol Biol. 2009;564:105-21. doi: 10.1007/978-1-60761-157-8_6.

PMID:
19544019
14.

Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals.

Delles C, Schiffer E, von Zur Muhlen C, Peter K, Rossing P, Parving HH, Dymott JA, Neisius U, Zimmerli LU, Snell-Bergeon JK, Maahs DM, Schmieder RE, Mischak H, Dominiczak AF.

J Hypertens. 2010 Nov;28(11):2316-22. doi: 10.1097/HJH.0b013e32833d81b7.

PMID:
20811296
15.

Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments.

Metzger J, Schanstra JP, Mischak H.

Anal Bioanal Chem. 2009 Mar;393(5):1431-42. doi: 10.1007/s00216-008-2309-0. Epub 2008 Aug 15. Review.

PMID:
18704377
16.

Mass spectrometry based proteomics in urine biomarker discovery.

Theodorescu D, Mischak H.

World J Urol. 2007 Oct;25(5):435-43. Epub 2007 Aug 17. Review.

PMID:
17703310
17.

CE-MS in biomarker discovery, validation, and clinical application.

Mischak H, Schanstra JP.

Proteomics Clin Appl. 2011 Feb;5(1-2):9-23. doi: 10.1002/prca.201000058. Epub 2010 Nov 11. Review.

PMID:
21280234
18.

Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction.

Quintana LF, Campistol JM, Alcolea MP, Bañon-Maneus E, Sol-González A, Cutillas PR.

Mol Cell Proteomics. 2009 Jul;8(7):1658-73. doi: 10.1074/mcp.M900059-MCP200. Epub 2009 Apr 7.

19.

Urinary proteomic biomarkers in coronary artery disease.

Zimmerli LU, Schiffer E, Zürbig P, Good DM, Kellmann M, Mouls L, Pitt AR, Coon JJ, Schmieder RE, Peter KH, Mischak H, Kolch W, Delles C, Dominiczak AF.

Mol Cell Proteomics. 2008 Feb;7(2):290-8. Epub 2007 Oct 19.

20.

The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications.

Kirkpatrick DS, Gerber SA, Gygi SP.

Methods. 2005 Mar;35(3):265-73. Epub 2005 Jan 12.

PMID:
15722223
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk